# Evaluation of the Efficacy of the Addition of Magnesium Sulfate to Morphine on the Occurrence of Acute Urinary Retention Following Epidural Anesthesia for Cesarean Section.

> **NCT06442995** · PHASE4 · RECRUITING · sponsor: **CHU de Reims** · enrollment: 290 (estimated)

## Conditions studied

- Urinary Retention

## Interventions

- **DRUG:** Injection of 500 mg magnesium sulfate + 2 mg morphine into the epidural space
- **DRUG:** Injection of Isotonic saline + 2 mg morphine into the epidural space

## Key facts

- **NCT ID:** NCT06442995
- **Lead sponsor:** CHU de Reims
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-16
- **Primary completion:** 2027-07
- **Final completion:** 2027-12
- **Target enrollment:** 290 (ESTIMATED)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06442995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06442995, "Evaluation of the Efficacy of the Addition of Magnesium Sulfate to Morphine on the Occurrence of Acute Urinary Retention Following Epidural Anesthesia for Cesarean Section.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06442995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*